SECsense Logo

Glucotrack, Inc. 8-K Report: Key Insights for Investors as of December 31, 2024

$GCTK
Form 8-K
Filed on: 2024-12-31
Source
Glucotrack, Inc. 8-K Report: Key Insights for Investors as of December 31, 2024

Based on the provided section of the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Glucotrack, Inc.
  • Entity Type: Corporation (DE - Delaware)
  • SEC CIK: 0001506983
  • SEC File Number: 001-41141
  • EIN: 98-0668934
  • Address: 301 Rte. 17 North Ste. 800, Rutherford, NJ 07070
  • Contact Number: (201) 842-7715
  1. Filing Type:
  • Form: 8-K (which is typically used to report significant events that shareholders should know about)
  1. Report Date:
  • Period End Date: December 31, 2024
  1. Stock Information:
  • Common Stock Symbol: GCTK
  • Exchange: NASDAQ
  1. Units of Measurement:
  • Currency: US Dollars (USD)
  • Shares: The report includes measurements in shares, indicating stock-related disclosures.
  1. Context Information:
  • Context ID: As of December 31, 2024, indicating this report is as of a specific date rather than a range.

Insights:

  • This report is likely to provide updates regarding the company's financial position or significant corporate events as of the end of 2024.
  • The use of the 8-K form suggests that there may be important announcements or updates regarding operations, financial condition, or other material changes that investors and stakeholders should be aware of.
  • The reference to shares and common stock indicates that the report may include information on stock performance, issuance, or other equity-related matters.

Overall, this brief snapshot indicates that Glucotrack, Inc. is preparing to disclose important information to its investors, which could impact stock performance and investor decisions. Further analysis would require more detailed financial data typically found in the body of the 8-K filing.